Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

Technology appraisal guidance
Reference number: TA118
Published: 24 January 2007
Last updated: 01 January 2012

Evidence

Supporting evidence

Review decision
Static List Review November 2015
Static List Review Paper November 2015 (PDF 165 KB)

Published:

16 January 2015